Study Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy Volunteers

This study has been terminated.

(Study terminated due to treatment-emergent serious adverse events)

Sponsor:

Information provided by (Responsible Party):

Astellas Pharma Inc

ClinicalTrials.gov Identifier:

NCT00870441

First received: March 25, 2009

Last updated: February 27, 2013

Last verified: June 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	April 2010
Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)